from ALS patients, advocates and members of Congress. In recent weeks the agency received more than 1,300 written comments from the ALS community supporting the treatment.
The powder-based drug is a combination of two older ingredients: a prescription medication for liver disorders and a dietary supplement associated with traditional Chinese medicine. Cambridge, Massachusetts-based Amylyx has patented the combination and says the chemicals work together to shield cells from premature death.Some ALS patients already take both drugs separately, sometimes paying $5,000 a month for the prescription component, according to physicians.
One outside group that analyzes the cost effectiveness of new treatments pegged the drug’s value at between between $9,100 and $30,700 per year. The Institute for Clinical and Economic Review also noted that many patients are expected to take Amylyx’s drug in combination with an older therapy, which costs over $170,000 per year.
Big Democratic/Marxists Party, and Big Pharma, working hand in hand to fleece the people. The COVID 'vaccine' didn't work to prevent infection, Lecanemab Alzheimer’s drug doesn't work, and many have doubts about the 'new ALS drug'
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: FOX10Phoenix - 🏆 83. / 68 Read more »
Source: NBCNewYork - 🏆 270. / 63 Read more »
Source: fox32news - 🏆 547. / 51 Read more »
Source: amNewYork - 🏆 336. / 59 Read more »
Source: WOKVNews - 🏆 247. / 63 Read more »